NewsLatest News

bt_bb_section_bottom_section_coverage_image

Today, on the International Day of Women and Girls in Science 2024, we celebrate the importance of achieving gender equality at work and we recognize the role that women and girls play in science and technology. At Biose Industrie we are proud that half of our employees are women – watch the video below to...

LBPs for Bacterial Vaginosis, Small Molecules for Parkinson’s and Metabolomic-based drug discovery: A Roundup of Microbiome Connect USA 2024

Review by Claire Derlot Head of Programs for LBP Development & Manufacturing A few weeks back, Nadine, Richard, Adrien, and I had the pleasure of attending the Boston-based microbiome drug development conference “Microbiome Connect USA 2024”. Spanning 3 days the event promised the chance to connect with the microbiome field, and learn about its latest...

7 South Korean Microbiome Developers to Watch in 2024

Introduction South Korea has emerged as a leading hub for innovative microbiome research and development, with a thriving biopharmaceutical industry and cutting-edge research institutions. In this article, we will highlight seven South Korean microbiome developers that are poised to make significant advancements in 2024. Korean Microbiome Developers Genome & Co Located in Seongnam-Si, Genome +...

Biose’s highlights from the 8th Microbiome Movement: Drug Development

Last month, Microbiome Movement returned to Boston for its 8th Drug Development summit. With 2023’s multiple regulatory approvals for C. difficile microbiome treatments, the event set out to platform microbial-based approaches beyond the condition. The event consisted of a three-track agenda divided across “Discovery & Pre-clinical”, “Translational & Clinical”, and “Manufacturing & Process development” tracks...

Microbiome Connect: Asia

Introduction Last month, Biose industrie had the privilege of speaking at Microbiome Connect: Asia. The two-day congress took place in Seoul, Korea, and was attended by microbiome enthusiasts across academia and industry alike. Given the rapidly growing APAC microbiome market, Biose were thrilled to hear from APAC voices on topics ranging from regulatory firsts to...

Biose Industrie & SBT Instruments enter collaboration to revolutionize bacterial enumeration within the live biotherapeutic market

Aurillac, France, May 29th, 2023   Biose Industrie, a contract development manufacturing organisation (CDMO) and a world-leader of live biotherapeutic product (LBP) process development and production, and SBT instruments, a bacteria-focused state-of-the-art industrial equipment supplier, announced a collaboration to implement rapid viable cell counts within Biose’s manufacturing process. The emerging field of live biotherapeutics faces...

Pharmabiotics 2023 Report – Standout LBP Development Presentations

The Pharmabiotics Conference & Partnering returned for 2023, bringing together cutting-edge microbiome researchers and drug developers. In the heart of Lyon 220 microbiome stakeholders gathered to explore key topics facing the field: from regulatory hurdles to considerations for spinning out. The event featured three panel discussions on developing a drug from “concept to consortia”, the...